Functional plasticity of macrophages: in situ reprogramming of tumor‐associated macrophages

The extent to which the functional heterogeneity of Mφs is dependent on the differentiation of functional sublineages remains unresolved. One alternative hypothesis proposes that Mφs are functionally plastic cells, which are capable of altering their functional activities progressively in response to progressively changing signaling molecules generated in their microenvironment. This “functional plasticity” hypothesis predicts that the functionally polarized Mφs in chronic pathologies do not represent Mφ sublineages but rather, are mutable phenotypes sustained by chronic signaling from the pathological environment. Solid TAMφs are chronically polarized to provide activities that support tumor growth and metastasis and suppress adaptive immune responses. In support of the functional plasticity hypothesis, administration of slow‐release microsphere‐encapsulated IL‐12 successfully reprogrammed TAMφs in situ, reducing Mφ support of tumor growth and metastasis and enhancing Mφ proimmunogenic activities. Increased knowledge of how Mφ function is regulated and how polarized Mφs can be reprogrammed in situ will increase our ability to control Mφ function in a variety of pathological states, including cancer and chronic inflammatory disease.

[1]  S. Masli,et al.  Anti‐inflammatory effects of tumour necrosis factor (TNF)‐α are mediated via TNF‐R2 (p75) in tolerogenic transforming growth factor‐β‐treated antigen‐presenting cells , 2009, Immunology.

[2]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling by ITAM-associated receptors , 2009, Nature Immunology.

[3]  Vishva Dixit,et al.  Death receptor signal transducers: nodes of coordination in immune signaling networks , 2009, Nature Immunology.

[4]  J. Suttles,et al.  Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype1 , 2008, The Journal of Immunology.

[5]  R. Apte,et al.  Interleukin-10 Promotes Pathological Angiogenesis by Regulating Macrophage Response to Hypoxia during Development , 2008, PloS one.

[6]  A. M. Houghton,et al.  Common origins of lung cancer and COPD , 2008, Nature Medicine.

[7]  M. Mack,et al.  Glucocorticoids induce an activated, anti‐inflammatory monocyte subset in mice that resembles myeloid‐derived suppressor cells , 2008, Journal of leukocyte biology.

[8]  R. Ádány,et al.  Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics , 2008, Journal of leukocyte biology.

[9]  J. O’Shea,et al.  Cytokine signaling modules in inflammatory responses. , 2008, Immunity.

[10]  I. Wang,et al.  Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis. , 2008, American journal of respiratory cell and molecular biology.

[11]  James A. Hutchinson,et al.  Macrophages Driven to a Novel State of Activation Have Anti-Inflammatory Properties in Mice1 , 2008, The Journal of Immunology.

[12]  E. Benveniste,et al.  Type I Interferons as Anti-Inflammatory Mediators , 2007, Science's STKE.

[13]  C. Elson,et al.  Molecular Mechanism of Lipopolysaccharide-Induced SOCS-3 Gene Expression in Macrophages and Microglia1 , 2007, The Journal of Immunology.

[14]  B. Graham-Evans,et al.  TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors. , 2007, Blood.

[15]  L. Ivashkiv,et al.  Crosstalk among Jak‐STAT, Toll‐like receptor, and ITAM‐dependent pathways in macrophage activation , 2007, Journal of leukocyte biology.

[16]  D. Greenhalgh,et al.  Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.

[17]  G. Parmiani,et al.  Tumor-released microvesicles as vehicles of immunosuppression. , 2007, Cancer research.

[18]  J. Suttles,et al.  IL-12 Rapidly Alters the Functional Profile of Tumor-Associated and Tumor-Infiltrating Macrophages In Vitro and In Vivo1 , 2007, The Journal of Immunology.

[19]  Yu-Tseung Liu,et al.  Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells , 2006, Nature Cell Biology.

[20]  Jun Kawai,et al.  Alternate transcription of the Toll-like receptor signaling cascade , 2006, Genome Biology.

[21]  Paolo Serafini,et al.  Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. , 2006, Seminars in cancer biology.

[22]  John Condeelis,et al.  Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.

[23]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[24]  A. Rakhmilevich,et al.  Synergistic Activation of Macrophages via CD40 and TLR9 Results in T Cell Independent Antitumor Effects1 , 2006, The Journal of Immunology.

[25]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[26]  D. Dormont,et al.  Macrophage activation switching: an asset for the resolution of inflammation , 2005, Clinical and experimental immunology.

[27]  S. Meijer,et al.  The Role of Macrophages in Tumor Development , 2005, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[28]  R. Jope,et al.  Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 , 2005, Nature Immunology.

[29]  J. Suttles,et al.  Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences1 , 2005, The Journal of Immunology.

[30]  J. Suttles,et al.  Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age‐associated microenvironmental changes , 2005, Immunological reviews.

[31]  A. Rakhmilevich,et al.  CD40 Ligation Activates Murine Macrophages via an IFN-γ-Dependent Mechanism Resulting in Tumor Cell Destruction In Vitro 1 , 2005, The Journal of Immunology.

[32]  G. Trinchieri,et al.  Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. , 2005, Cancer research.

[33]  J. Utikal,et al.  Interleukin‐4 and Dexamethasone Counterregulate Extracellular Matrix Remodelling and Phagocytosis in Type‐2 Macrophages , 2005, Scandinavian journal of immunology.

[34]  J. Suttles,et al.  Functional plasticity of macrophages: reversible adaptation to changing microenvironments , 2004, Journal of leukocyte biology.

[35]  S. Rosenberg,et al.  Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.

[36]  B. Brew,et al.  Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification , 2004, Journal of leukocyte biology.

[37]  P. Barnes Alveolar Macrophages as Orchestrators of COPD , 2004, COPD.

[38]  M. Fenton,et al.  TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. , 2003, Molecular interventions.

[39]  D. Mosser,et al.  The many faces of macrophage activation , 2003, Journal of leukocyte biology.

[40]  M. Sabel,et al.  Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. , 2002, Cancer research.

[41]  P. Finan,et al.  IL‐10 expression profiling in human monocytes , 2002, Journal of leukocyte biology.

[42]  J. Norton,et al.  Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. , 2002, Cancer research.

[43]  Peter J. Murray,et al.  Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.

[44]  D. Laskin,et al.  Functional heterogeneity in liver and lung macrophages , 2001, Journal of leukocyte biology.

[45]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[46]  Constantin E. Orfanos,et al.  Alternative versus Classical Activation of Macrophages , 2000, Pathobiology.

[47]  D. Mullins,et al.  Tumor‐induced immune dysfunction: the macrophage connection , 1998, Journal of leukocyte biology.

[48]  D. Chaussabel,et al.  IL‐10 up‐regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)‐activated macrophages: improved control of Trypanosoma cruzi infection , 1998, Clinical and experimental immunology.

[49]  Yoshiyuki Niho,et al.  Role of IL-10 in the Crossregulation of Prostaglandins and Cytokines in Monocytes , 1998, Acta Haematologica.

[50]  G. Trinchieri,et al.  Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. , 1998, The Journal of clinical investigation.

[51]  B. Becher,et al.  Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia , 1996, Glia.

[52]  J. Suttles,et al.  T-Cell Signaling of Macrophage Activation: Cell Contact-Dependent and Cytokine Signals , 1995 .

[53]  G. Trinchieri,et al.  Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production , 1995, The Journal of experimental medicine.

[54]  L. Luistro,et al.  Antitumor and antimetastatic activity of interleukin 12 against murine tumors , 1993, The Journal of experimental medicine.

[55]  C. Nathan,et al.  Modulation of Macrophage Function by Transforming Growth Factor β, Interleukin‐4, and Interleukin‐10 a , 1993, Annals of the New York Academy of Sciences.

[56]  Jelena S. Bezbradica,et al.  Integration of cytokine and heterologous receptor signaling pathways , 2009, Nature Immunology.

[57]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[58]  E. Raz Organ-specific regulation of innate immunity , 2007, Nature Immunology.

[59]  R. Diegelmann,et al.  Wound healing: an overview of acute, fibrotic and delayed healing. , 2004, Frontiers in bioscience : a journal and virtual library.

[60]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[61]  C. Haslett,et al.  MECHANISMS OF STEROID ACTION AND RESISTANCE IN INFLAMMATION Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation , 2003 .

[62]  G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[63]  R. Schreiber Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity. , 1984, Contemporary topics in immunobiology.